Pharmyn ApS: Financial statements 2021
CVR: 37133892
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 12,488 and a net result of DKK 12,244 compared with DKK -20,728 the year before. Equity in the 2021 report amounted to DKK 33,894. The solvency ratio was 76.9%.
- Gross Profit
- DKK 12,488
- Profit/Loss
- DKK 12,244
- Equity
- DKK 33,894
- Total Assets
- DKK 44,067
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 12 t. | 12 t. | 34 t. | 0 |
| 2020 | - | -20 t. | -21 t. | 22 t. | 0 |
| 2019 | - | 108 | 0 | 42 t. | 1 |
| 2018 | - | 288 | 88 | 42 t. | 0 |
| 2017 | - | -4 t. | -4 t. | 42 t. | - |
Official annual report
Find more companies like Pharmyn ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Pharmyn ApS has published its annual report for 2020. Gross profit came to DKK -20,104, and the net result was DKK -20,728.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662.